MedTrace Logo

Tool to Improve Treatment Adherence and Outcomes at Grady Liver Clinic

NCT03831555 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2019-02-06

No results posted yet for this study

Summary

The purpose of this study is to learn more about what psychological and social factors affect people in how they take their hepatitis C medications.

Conditions

  • Hepatitis C

Interventions

BEHAVIORAL

PREP-C

The Psychosocial Readiness Evaluation and Preparation for Hepatitis C Treatment (PREP-C) tool assesses a patient's psychosocial readiness to start HCV treatment. There are nine sections in the survey: 1. Motivation: reasons client wants to begin HCV treatment, concerns about treatment, and the importance of treatment 2. Information: knowledge about HCV treatment and one's own HCV disease status 3. Medication Adherence: current prescribed medications and adherence to them in the prior month 4. Self-efficacy: self-confidence about adhering to HCV treatment 5. Social Support and Stability: stability of financial, housing, and social support resources 6. Alcohol and substance use: alcohol and substance use behaviors and current treatment 7. Psychiatric Stability: current psychiatric status, previous and current treatment 8. Energy Level: sleep and fatigue 9. Cognitive Functioning: perceived difficulty with communication in health care setting, problem-solving ability, and memory.

Sponsors & Collaborators

  • Emory University

    lead OTHER

Principal Investigators

  • Lesley Miller, MD · Emory University

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-06-05
Primary Completion
2018-05-01
Completion
2018-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03831555 on ClinicalTrials.gov